Biography:
Tehreem Fatima has her expertise in evaluating cancer treatments and a passion for improving outcomes in oncology. With years of experience in biomedical research, she has contributed to developing innovative strategies for tackling treatment-resistant cancers like glioblastoma. Her research bridges molecular biology and therapeutic applications, focusing on histone deacetylase and DNA repair inhibitors. Tehreem's work aims to pave the way for more effective, personalized cancer treatments.
The effects of belinostat and long-term AsiDNA treatment on gene expression in glioblastoma